Literature DB >> 27634960

Histopathologic Analysis of Cerebral Autosomal Recessive Arteriopathy with Subcortical Infarcts and Leukoencephalopathy (CARASIL): A Report of a New Genetically Confirmed Case and Comparison to 2 Previous Cases.

Shinji Ito1, Masaki Takao1, Toshio Fukutake1, Hiroyuki Hatsuta1, Sayaka Funabe1, Nobuo Ito1, Yutaka Shimoe1, Toshiro Niki1, Imaharu Nakano, Masashi Fukayama1, Shigeo Murayama1.   

Abstract

Cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy (CARASIL) is a nonhypertensive hereditary cerebral small vessel disease that is caused by mutations in a single gene, HTRA1. The HTRA1 protein normally represses transforming growth factor-β (TGF-β) signaling and its mutations result in vascular changes. Ten homozygous, 1 compound heterozygous, and 1 homozygous frameshift mutation have been identified in the HTRA1 gene of patients with genetically confirmed CARASIL. However, few studies have compared neuropathologic findings in patients with the same or different mutations in HTRA1. We analyzed histopathologic alterations in 3 autopsied patients with genetically confirmed CARASIL: 2 of them had the HTRA1 p.R302X mutation and 1 had the HTRA1 p.A252T mutation. All 3 had similar cerebral arteriopathy showing myointimal proliferation, multi-layering and splitting of elastic laminae, and marked loss of medial smooth muscle cells. One CARASIL patient with the p.R302X mutation had atherosclerosis-like intimal thickening and arteriolosclerosis in the arteries of visceral organs, indicating that atherosclerotic changes are not confined to the intracranial vasculature but can occur throughout the body. CARASIL is a unique hereditary disease that shows similar neuropathology, systemic vascular pathology, and other TGF-β1-related pathology associated with HTRA1 mutation.
© 2016 American Association of Neuropathologists, Inc. All rights reserved.

Entities:  

Keywords:  Atherosclerosis; Autopsy; CARASIL; Genetic; HTRA1; Stroke; TGF-β1.; Vascular

Year:  2016        PMID: 27634960     DOI: 10.1093/jnen/nlw078

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  7 in total

1.  A new case of autosomal dominant small vessel disease carrying a novel heterozygous mutation in HTRA1 gene: 2-year follow-up.

Authors:  A R Pati; C Battisti; I Taglia; P Galluzzi; M Bianchi; A Federico
Journal:  Neurol Sci       Date:  2018-03-15       Impact factor: 3.307

2.  Candesartan prevents arteriopathy progression in cerebral autosomal recessive arteriopathy with subcortical infarcts and leukoencephalopathy model.

Authors:  Taisuke Kato; Ri-Ichiroh Manabe; Hironaka Igarashi; Fuyuki Kametani; Sachiko Hirokawa; Yumi Sekine; Natsumi Fujita; Satoshi Saito; Yusuke Kawashima; Yuya Hatano; Shoichiro Ando; Hiroaki Nozaki; Akihiro Sugai; Masahiro Uemura; Masaki Fukunaga; Toshiya Sato; Akihide Koyama; Rie Saito; Atsushi Sugie; Yasuko Toyoshima; Hirotoshi Kawata; Shigeo Murayama; Masaki Matsumoto; Akiyoshi Kakita; Masato Hasegawa; Masafumi Ihara; Masato Kanazawa; Masatoyo Nishizawa; Shoji Tsuji; Osamu Onodera
Journal:  J Clin Invest       Date:  2021-11-15       Impact factor: 14.808

Review 3.  HTRA1-Related Cerebral Small Vessel Disease: A Review of the Literature.

Authors:  Masahiro Uemura; Hiroaki Nozaki; Taisuke Kato; Akihide Koyama; Naoko Sakai; Shoichiro Ando; Masato Kanazawa; Nozomi Hishikawa; Yoshinori Nishimoto; Kiran Polavarapu; Atchayaram Nalini; Akira Hanazono; Daisuke Kuzume; Akihiro Shindo; Mohammad El-Ghanem; Arata Abe; Aki Sato; Mari Yoshida; Takeshi Ikeuchi; Ikuko Mizuta; Toshiki Mizuno; Osamu Onodera
Journal:  Front Neurol       Date:  2020-07-03       Impact factor: 4.003

4.  Identification and Characterization of Plasmin-Independent Thrombolytic Enzymes.

Authors:  Md Mehedi Hassan; Shirina Sharmin; Hyeon-Jin Kim; Seong-Tshool Hong
Journal:  Circ Res       Date:  2020-12-09       Impact factor: 17.367

5.  Proteomic profiling in cerebral amyloid angiopathy reveals an overlap with CADASIL highlighting accumulation of HTRA1 and its substrates.

Authors:  Christof Haffner; Martin Dichgans; Andreas Zellner; Stephan A Müller; Barbara Lindner; Nathalie Beaufort; Annemieke J M Rozemuller; Thomas Arzberger; Nils C Gassen; Stefan F Lichtenthaler; Bernhard Kuster
Journal:  Acta Neuropathol Commun       Date:  2022-01-24       Impact factor: 7.801

6.  Novel mutations in HTRA1-related cerebral small vessel disease and comparison with CADASIL.

Authors:  Chen Zhang; Honghua Zheng; Xin Li; Shaowu Li; Wei Li; Ziwei Wang; Songtao Niu; Xingao Wang; Zaiqiang Zhang
Journal:  Ann Clin Transl Neurol       Date:  2022-09-01       Impact factor: 5.430

7.  Educational Case: Etiologies, Mechanisms, and Treatment of Stroke.

Authors:  Lymaries Velez; Steven Toffel; Jorge Trejo-Lopez; Jesse L Kresak; Stacy G Beal
Journal:  Acad Pathol       Date:  2020-01-26
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.